FLJ45079 inhibitors are a class of chemical compounds that specifically target the FLJ45079 gene or its protein product. This gene encodes a protein that is involved in various cellular processes, potentially including regulatory pathways, signaling cascades, and gene expression mechanisms. FLJ45079 inhibitors are designed to modulate the activity of this protein, leading to downstream effects on the biological functions it controls. These compounds typically interact with the protein by binding to active or allosteric sites, thus altering its conformation or enzymatic activity. By inhibiting FLJ45079, these compounds may interfere with the cellular pathways in which the protein plays a crucial role, making them significant in research contexts where FLJ45079 function is of interest.
From a chemical perspective, FLJ45079 inhibitors may belong to various structural families, each characterized by distinct chemical scaffolds and functional groups. The design and synthesis of these inhibitors often focus on achieving high specificity and affinity for the FLJ45079 protein to minimize off-target effects. Researchers may explore a range of organic chemistry techniques, including structure-based design, to develop these molecules. In terms of physical properties, FLJ45079 inhibitors can vary widely in their molecular weights, hydrophobicity, and solubility, which can influence their ability to permeate cellular membranes and interact with the intracellular protein target. The chemical diversity of FLJ45079 inhibitors reflects the complexity of modulating protein function at the molecular level.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Inhibits PI3K, a kinase that can be involved in various signaling pathways, potentially affecting FLJ45079 activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A specific inhibitor of PI3K, which can alter downstream processes potentially related to FLJ45079 function. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Binds to mTOR and inhibits its function; mTOR is a key regulator in cell growth and metabolism. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Inhibits MEK, which is part of the MAPK/ERK pathway, possibly influencing FLJ45079's role in cell signaling. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
A selective inhibitor of MEK1/2, thereby affecting the MAPK/ERK pathway upstream of FLJ45079. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAP kinase, potentially modifying the cellular response where FLJ45079 is implicated. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, which might alter stress response signaling pathways involving FLJ45079. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A proteasome inhibitor that can affect protein degradation pathways, potentially affecting FLJ45079 stability. | ||||||
Z-VAD-FMK | 187389-52-2 | sc-3067 | 500 µg | $75.00 | 256 | |
An inhibitor of caspases, can affect apoptotic pathways, possibly influencing processes involving FLJ45079. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Inhibits histone deacetylases, which can affect chromatin structure and gene expression, including FLJ45079. | ||||||